Radioiodine Treatment of Differentiated Thyroid Cancer at CNMU, Rajshahi

Authors

  • MM Ahasan Center for Nuclear Medicine and Ultrasound, Rajshahi
  • FU Ahmed Center for Nuclear Medicine and Ultrasound, Rajshahi
  • SM Bodrudozza Rajshahi Medical College, Rajshahi
  • SMK Hasan Myesol Modern Hospital, Noakhali
  • MN Khanam Center for Nuclear Medicine and Ultrasound, Rajshahi

DOI:

https://doi.org/10.3329/taj.v16i2.3882

Keywords:

radioiodine treatement, thyroid cancer

Abstract

A retrospective study has been conducted on 19 patients who attended at CNMU, Rajshahi with
differentiated thyroid cancer, treated with radioiodine for ablation of residual tissue after
thyroidectomy. The patients included in this study were between 06 to 70 years of age, the mean
age being about 36 years. The main objective of the study was to evaluate the response of the
radioiodine therapy in patient with differentiated thyroid cancer after surgery. The incidence of
papillary, follicular and mixed variety was found in approximately 69%, 26% and 5% cases
respectively. Result showed that the incidence of thyroid cancer were found more,
approximately 58% in the age group 21-40 years. Results also showed that papillary carcinoma
involved approximately 23% in male and 77% in female. It was also found that approximately
89% patients were treated successfully by single dose of radioiodine.

doi: 10.3329/taj.v16i2.3882

TAJ December 2003; Vol.16(2): 54-57

Downloads

Download data is not yet available.
Abstract
84
PDF
60

Downloads

How to Cite

Ahasan, M., Ahmed, F., Bodrudozza, S., Hasan, S., & Khanam, M. (2009). Radioiodine Treatment of Differentiated Thyroid Cancer at CNMU, Rajshahi. TAJ: Journal of Teachers Association, 16(2), 54–57. https://doi.org/10.3329/taj.v16i2.3882

Issue

Section

Original Articles